Databricks Launches Agent Bricks: A New Approach to Building AI Agents
Agent Bricks automatically optimizes AI agents on customers' unique data to deliver cost-efficient, trustworthy agents SAN FRANCISCO, June 11, 2025 /PRNewswire/ -- Data + AI Summit -- Databricks, the Data and AI company, today introduced Agent...
![EARLY CHRONIC KIDNEY DISEASE (CKD) INTERVENTION COULD SAVE AUSTRALIA $1 BILLION A YEAR[1]](http://prnewswire.vietreader.com/thumb/190x300/2025-06/early-chronic-kidney-disease-ckd-intervention-could-save-australia-1-billion-a-year1-1.gif)
EARLY CHRONIC KIDNEY DISEASE (CKD) INTERVENTION COULD SAVE AUSTRALIA $1 BILLION A YEAR[1]
SYDNEY, June 7, 2025 /PRNewswire/ -- New modelling highlights the potential societal, economic and environmental benefits of early chronic kidney disease (CKD) intervention which could change lives for thousands of Australians. Australia could save...
SOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR
BOSTON and ROLLE, Switzerland, April 29, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and global leader in data-driven medicine, today announced the expansion of its ongoing collaboration with...
Docquity and AstraZeneca's Patient Support Program Educates Tens of Thousands in Thailand
OAZisCare, digitally powered by DocquityCare, has advanced patient education and adherence for cancer care and RSV vaccines since 2024 The collaboration helps tackle Southeast Asia's healthcare needs, with 85.7% of doctors noting immunization rates...
Global Times: Believing in China, believing in tomorrow
BEIJING, April 12, 2025 /PRNewswire/ -- "Believing in China" has become a buzz phrase this spring. "For us, opportunities exist in all Chinese cities" and "China's scientific and technological innovation ecosystem injects surging momentum into...
Lunit to Present AI Study on EGFR Mutation Prediction in NSCLC at AACR 2025 in Collaboration with AstraZeneca
AI-powered model predicts EGFR mutations from H&E-stained slides, demonstrating robust performance across diverse clinical settings and helping overcome barriers to molecular testing in NSCLC SEOUL, South Korea, March 26, 2025 /PRNewswire/ --...
Syneron Bio Announces Strategic Collaboration with AstraZeneca
BEIJING, March 21, 2025 /PRNewswire/ -- Syneron Bio, a cutting-edge oral macrocyclic peptide drug biotech company, announced today a strategic collaboration with the global biopharmaceutical leader AstraZeneca to develop potential first-in-class...
Harbour BioMed Enters into Global Strategic Collaboration with AstraZeneca to Discover and Develop Next-Generation Therapeutic Antibodies
SHANGHAI, CAMBRIDGE, Mass. and ROTTERDAM, Netherlands, March 21, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics in...
Leading Healthcare Institutions Adopt MSK-ACCESS® for Liquid Biopsy Testing
SOPHiA GENETICS enables institutions across the globe to launch world-class oncology testing BOSTON, MA and ROLLE, Switzerland, Feb. 24, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a pioneer in AI healthcare technology and a leader in...
Dubai to Gather More Than 30 Heads of State and Government, Global Leaders at the World Governments Summit 2025
Delegations from 140 governments, global tech leaders gather in Dubai on February 11-13 to accelerate solutions for the world's greatest challenges Among notable guests – 30 heads of state and governments, the Managing Director of IMF, CEOs of...